Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lactose (1 trial)
silymarin (1 trial)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Hepatitis C (Phase 3)
Hepatitis E (Phase 3)
Trials (1 total)
Trial APIs (2 total)